Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Acquired Immune Deficiency Syndrome
8%
Adolescence
5%
Adverse Event
7%
African Trypanosomiasis
7%
Antibiotic Resistance
13%
Antibiotics
5%
Antigen
8%
Antimicrobial Agent
5%
Antiretroviral Therapy
22%
Arm
7%
Bedaquiline
6%
Bloodstream Infection
6%
Clinical Trial
8%
Clinician
6%
Cohort Analysis
5%
Cohort Effect
6%
COVID-19
11%
Cross Sectional Study
14%
Cutaneous Leishmaniasis
9%
Dengue Fever
5%
Diagnosis
5%
Diagnostic Accuracy
9%
Diagnostic Test
5%
Diseases
41%
Drug Resistant Tuberculosis
18%
Ebolavirus
9%
Ethiopia
24%
Gonorrhea
5%
Health Care Cost
6%
Health Care Personnel
15%
HIV Test
6%
Human immunodeficiency virus
93%
Human Immunodeficiency Virus Infection
9%
Infection
41%
Infectious Disease
5%
Logistic Regression Analysis
5%
Low and Middle Income Countries
8%
Malaria
37%
Malaria Falciparum
9%
Men Who Have Sex with Men
20%
Meta-Analysis
7%
Mixed Infection
5%
Mixed Methods
6%
Monkeypox
6%
Multidrug Resistant Tuberculosis
7%
Neglected Tropical Diseases
5%
Neisseria gonorrhoeae
5%
Observational Study
5%
Odds Ratio
6%
Oral
11%
Parasite (Microbiology)
9%
Pathogen
9%
Patient Referral
5%
Plasmodium
5%
Pre-Exposure Prophylaxis
16%
Prevalence
24%
Primary Health Care
6%
Prospective Cohort Study
5%
Public Health
10%
Quinolone Derivative
9%
Randomized Controlled Trial
5%
Rapid Diagnostic Test
16%
Republic of South Africa
7%
Retrospective Cohort Study
11%
Retrospective Study
5%
Returning Traveler
9%
Rifampicin
20%
Schistosomiasis
6%
Sexual Behavior
5%
Sexually Transmitted Disease
14%
Systematic Review
13%
Treatment Outcome
10%
Tropical Disease
6%
Tuberculosis
36%
Tuberculosis Treatment
7%
Typhoid Fever
5%
Virus Infection
11%
Visceral Leishmaniasis
13%
Immunology and Microbiology
Acquired Immune Deficiency Syndrome
9%
Antibiotic Resistance
24%
Antibiotic Sensitivity
8%
Antigen
16%
Antimicrobial Agent
7%
Bacterium
7%
Blood Plasma
8%
CD4 Lymphocyte Count
9%
Chlamydiae
5%
Cladistics
16%
Cohort Effect
8%
Coinfection
12%
COVID-19
13%
Cutaneous Leishmaniasis
10%
Cytotoxic T-Cell
5%
Drug Resistance
5%
Ebola Virus
5%
Epidemiology
8%
Escherichia coli
9%
Hepatitis C
5%
Hepatitis C Virus
5%
Human immunodeficiency virus
78%
Human Immunodeficiency Virus 1
13%
Human Immunodeficiency Virus Infection
11%
Immune Reconstitution Inflammatory Syndrome
6%
Immune Response
5%
In Vitro
9%
Infection
100%
Infectious Agent
16%
Infectious Disease
98%
Klebsiella pneumoniae
6%
Leishmania
8%
Leishmaniasis
8%
Lineage
7%
Malaria
32%
Minimum Inhibitory Concentration
13%
Monkeypox
6%
Monkeypox Virus
7%
Neisseria
10%
Neisseria gonorrhoeae
20%
Neutralizing Antibody
5%
Parasite
13%
Plasmodium
6%
Plasmodium falciparum
10%
Prevalence
38%
Real Time Polymerase Chain Reaction
5%
Ribonucleic Acid
6%
Salmonella
14%
Schistosomiasis
7%
Serology
5%
Serotype
8%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Staphylococcus aureus
5%
Susceptibility
12%
T Cell
9%
Viral Load
9%
Virus
7%
Virus Infection
11%
Visceral Leishmaniasis
24%
Whole Genome Sequencing
6%
Nursing and Health Professions
Acquired Immune Deficiency Syndrome
8%
Adherence
5%
Antiretroviral Therapy
16%
CD4 Lymphocyte Count
5%
Cohort Analysis
5%
Confidence Interval
6%
COVID-19
6%
Cross-Sectional Study
5%
Diagnostic Accuracy
7%
Diagnostic Test
10%
Diseases
19%
Health Care Personnel
6%
HIV Test
5%
Human immunodeficiency virus
57%
Human Immunodeficiency Virus Infection
11%
Infection
11%
Malaria
18%
Men Who Have Sex with Men
6%
Practice Guideline
7%
PrEP
5%
Prevalence
12%
Rifampicin
5%
Sexually Transmitted Disease
5%
Skin Leishmaniasis
7%
Systematic Review
5%
Treatment Outcome
5%
Tuberculosis
15%
Virus Infection
5%
Visceral Leishmaniasis
5%
World Health Organization
6%